MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Cognitive and Motor aspects of a Brazilian population with Parkinson´s disease and Impulse Control Disorders and/or Related Behaviors – an observational study.

    B. Veiga, C. da Silva, L. Barcelos, H. Ferraz, S. Silva, V. Borges (São Paulo, Brazil)

    Objective: We analysed if Impulse Control Disorders (ICDs) and/or Related Behaviors (RBs) were associated with levodopa-induced dyskinesia (LIDs) in Brazilian patients with Parkinson´s disease (PD)…
  • 2022 International Congress

    Multimodal MRI assessment of the substantia nigra in premotor and motor stages of parkinsonism

    J. Pasquini, MJ. Firbank, L. Best, V. Foster, V. Silani, G. Petrides, DJ. Brooks, KN. Anderson, N. Pavese (Newcastle upon Tyne, United Kingdom)

    Objective: To investigate substantia nigra (SN) MRI abnormalities through Neuromelanin (NM) and diffusion MRI (dMRI) with Neurite Orientation Dispersion and Density Index (NODDI) in the…
  • 2022 International Congress

    Assessment of novel diffusion MRI metrics of cortical microstructure in the genetic continuum of Parkinson’s disease

    M. Torso, D. Tzaferou, M. Valotti, J. Hardwidge, I. Hardingham, Q. Guo, R. Comley, S. Chance, G. Ridgway (Oxford, United Kingdom)

    Objective: To investigate novel cortical diffusivity metrics in Parkinson’s disease (PD), including both prodromal and established genetic PD, alongside sporadic PD and healthy controls (HC).…
  • 2022 International Congress

    Identifying meaningful symptoms and impacts of disease for patients with early Parkinson’s disease

    J. Mammen, R. Speck, R. Dorsey, M. Müller, P. Yang, S. Jensen-Roberts, M. Kostrzebski, J. Cosman, J. Hellsten, J. Crawford, G. Stebbins, J. Cedarbaum, T. Simuni, T. Dam, K. Ward Barowicz, D. Stephenson, J. Adams (Providence, USA)

    Objective: To explore meaningful symptoms and impacts of disease on daily living in individuals with early-stage Parkinson’s disease (PD). Background: Critical Path for Parkinson’s (CPP)…
  • 2022 International Congress

    Gut dysbiosis in patients with dementia with Lewy bodies

    H. Nishiwaki, M. Ito, T. Hamaguchi, K. Kashihara, T. Maeda, Y. Tsuboi, M. Katsuno, M. Hirayama, K. Ohno (Nagoya, Japan)

    Objective: To identify intestinal bacteria that are changed in DLB alone or in both DLB and cognitive decline in Parkinson’s disease (PD). Background: Gut microbiota…
  • 2022 International Congress

    Cortical oscillatory feature-based classification of Parkinson’s disease with freezing gait

    A. Singh, S. Roy, KC. Santosh (Vermillion, USA)

    Objective: The objective of this study was to determine the resting-state cortical oscillations and the machine learning model that best classifies Parkinson’s disease (PD) patients…
  • 2022 International Congress

    Telemedicine in a Himalayan country: unlocking the barrier in the management of Parkinson’s Disease

    R. Ojha, B. Gajurel, R. Karn, R. Rajbhandari, G. Nepal, J. Yadav, P. Joshi (Kathmandu, Nepal)

    Objective: To evaluate the feasibility of telemedicine among PD patients in Nepal. Background: Nepal is a mountainous country occupying about 85% by Himalayas and hills…
  • 2022 International Congress

    Thalamic white matter macrostructure and subnuclei volumes in Parkinson’s disease depression

    R. Bhome, A. Zarkali, G. Thomas, J. Iglesias, J. Cole, R. Weil (London, United Kingdom)

    Objective: To investigate thalamic subnuclei volume and macrostructural white matter changes in Parkinson’s disease (PD) depression. Background: Depression is a common neuropsychiatric feature of Parkinson’s…
  • 2022 International Congress

    Assessment of non-motor symptoms of Parkinson’s disease in the long-term follow-up after the cell therapy

    V. Chyzhyk, A. Boika, V. Ponomarev (Minsk, Belarus)

    Objective: To evaluate the results of the introduction of MSCs on the non-motor symptoms in patients with PD within 12 months after the cell therapy.…
  • 2022 International Congress

    Characterising Natural Killer cells in early Parkinson’s disease

    J. Holbrook, B. Patel, M. Camacho, C. Williams-Gray (Cambridge, United Kingdom)

    Objective: To determine whether the number and phenotype of Natural Killer (NK) cells in the blood is altered in early Parkinson’s disease (PD). Background: Accumulating…
  • « Previous Page
  • 1
  • …
  • 421
  • 422
  • 423
  • 424
  • 425
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley